Genetic immunization with Hantavirus vaccine combining expression of G2 glycoprotein and fused interleukin-2

Genetic Vaccines and Therapy

Volumn 6, Issue , 2008, Pages

  Hao, Huang ^a,b   Xiu, Li ^a   Zehua, Zhang ^a   Min, Jia ^a   Hongbo, Hu ^a   Zhihong, Wu ^a   Zhenhua, Zhu ^a   Xiaohong, Wan ^a   Hanju, Huang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b First Hospital of Wuhan   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC PROTEIN; DNA VACCINE; GLYCOPROTEIN G2 INTERLEUKIN 2 FUSION PROTEIN; HANTAVIRUS VACCINE; HYBRID PROTEIN; NEUTRALIZING ANTIBODY; PLASMID VECTOR; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CELL STRAIN COS1; CELLULAR IMMUNITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE CONSTRUCT; GENETIC IMMUNIZATION; HANTAVIRUS; HUMORAL IMMUNITY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; SPLEEN CELL; TRANSGENE; TRANSIENT EXPRESSION;

EUKARYOTA; HANTAVIRUS; MUS;

EID: 55649108896     PISSN: None     EISSN: 14790556     Source Type: Journal    
DOI: 10.1186/1479-0556-6-15     Document Type: Article

References (26)

1. Peters CJ Simpson GL Levy H Spectrum of Hantavirus infection: hemorrhagic fever with renal syndrome and Hantavirus pulmonary syndrome Annu Rev Med 1999, 50:531-45 10.1146/annurev.med.50.1.531 10073292
2. Peters CJ Khan AS Hantavirus pulmonary syndrome: The new American hemorrhagic fever Clin Infect Dis 2002 34 1224 31 10.1086/339864 11941549
3. McCaughey C Hart CA Hantaviruses J MedMicrobiol 2000, 49(7):587-99
4. Schmaljohn C Hooper JW Bunyaviridae: The viruses and their replication Fields Virology Lippincott Williams and Wilkins, Baltimore Knipe DM, Howley PM 4 2001 2.2
5. Terajima M van Epps HL Li D HL Generation of recombinant vaccinia viruses expressing Puumala virus proteins anduse in isolating cytotoxic T cells specific for Puumala virus Virus Res 2002, 84:67-7 10.1016/ S0168-1702(01)00416-6 11900840
6. Yoshimatsu K Yoo YC Yoshida R Ishihara C Azuma I Arikawa J Protective immunity of Hantaan virus nucleocapsid and envelope protein studied using baculovirus-expressed proteins Arch Virol 1993, 130:365-76 10.1007/ BF01309667 8517793
7. Premenko-Lanier M Rota PA Rhodes G Verhoeven D Barouch DH Lerche NW Letvin NL Bellini WJ McChesney MB DNA vaccination of infants in the presence of maternal antibody: A measles model in the primate Virology 2003, 307:67-75 10.1016/S0042-6822(02)00036-3 12667815
8. Donnelly JJ Liu MA Ulmer JB Antigen presentation and DNA vaccines Am J Respir Crit Care Med 2000, 162:190-3
9. Bucht G Sjölander KB Eriksson S Lindgren L Lundkvist A Elgh F Modifying the cellular transport of DNAbased vaccines alters the immune response to hantavirus nucleocapsid protein Vaccine 2001, 19:3820-9 10.1016/S0264-410X(01)00151-7 11427253
10. Custer DM Thompson E Schmaljohn CS Ksiazek TG Hooper JW Schmaljohn Active and passive vaccination against hantavirus pulmonary syndrome with Andes virus M genome segment-based DNA vaccine J Virol 2003, 77:9894-905 224585 12941899 10.1128/JVI.77.18.9894-9905.2003
11. Hooper JW Custer DM Thompson E Schmaljohn CS DNA vaccination with hantavirus M segment elic its neutralizing antibodies and protects against seoul virus infection Virology 1999, 255:269-78 10.1006/ viro.1998.9586 10069952
12. Xiaohong W Hanju H Gang R Cloning and Transient Expression of the Gene Encoding Human Hantavirus H8205 Strain G2 Glycoprote in in Mammalian Cells J Huazhong Univ Sci Tech (Health Sci) 2002, 31:230-33
13. Barouch DH Craiu A Kuroda MJ Schmitz JE Zheng XX Santra S Frost JD Krivulka GR Lifton MA Crabbs CL Heidecker G Perry HC Davies ME Xie H Nickerson CE Steenbeke TD Lord CI Montefiori DC Strom TB Shiver JW Lewis MG Letvin NL Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys Proc Natl Acad Sci USA 2000, 97:4192-7 18194 10759543 10.1073/pnas.050417697
14. Barouch DH Santra S Tenner-Racz K Racz P Kuroda MJ Schmitz JE Jackson SS Lifton MA Freed DC Perry HC Davies ME Shiver JW Letvin NL Potent CD4- T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSF J Immunol 2002, 168:562-8 11777947
15. Chou CF Shen S Tan YJ Fielding BC Tan TH Fu J Xu Q Lim SG Hong W A novel cell-based binding assay system reconstituting interaction between SARS-CoV S protein and its cellular receptor J Virol Methods 2005, 123:41-8 10.1016/j.jviromet.2004.09.008 15582697
16. Waldmann TA The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design Nat Rev Immunol 2006, 6:595-601 10.1038/nri1901 16868550
17. Li WR Niu B Wang JW Feng ZJ Wang DX Coexpression of interleukin-2 enhances the immunization effect of a DNA vaccine expressing herpes simplex 1 glycoprotein D Acta Virol 2006, 50:251-6 17177610
18. Ulrich R Lundkvist A Meisel H Koletzki D Sjölander KB Gelderblom HR Borisova G Schnitzler P Darai G Krüger DH Chimaeric HBV core particles carrying a defined segment of Puumala Hantavirus nucleocapsid protein evoke protective immunity in an animal model Vaccine 1998, 16:272-80 10.1016/S0264-410X(97)00172-2 9607042
19. Wong HT Cheng SC Sin FW Chan EW Sheng ZT Xie Y A DNA vaccine against foot-and-mouth disease elicits an immune response in swine which is enhanced by co-administration with interleukin-2 Vaccine 2002, 20:2641-7 10.1016/S0264-410X(02)00212-8 12034088
20. Sin JI Kim JJ Boyer JD Ciccarelli RB Higgins TJ Weiner DB In vivo modulation of vaccine-induced immune responses toward a Th1 phenotype increases potency and vaccine effectiveness in a herpes simplex virus type 2 mouse model J Virol 1999, 73:501-9 103857 9847356
21. Du DW Jia ZS Li GY Zhou YY HBV DNA vaccine with adjuvant cytokines induced specific immune responses against HBV infection World J Gastroenterol 2003, 9:108-11 12508362
22. Rosinha GM Myioshi A Azevedo V Splitter GA Oliveira SC Molecular and immunological characterisation of recombinant Brucella abortus glyceraldehyde- 3-phosphate-dehydrogenase, a T- and B-cell reactive protein that induces partial protection when co-administered with an interleukin-12-expressing plasmid in a DNA vaccine formulation J Med Microbiol 2002, 51:661-71 12171297
23. Hooper JW Custer DM Thompson E Schmaljohn CS DNA vaccination with the Hantaan virus M gene protects Hamsters against three of four HFRS hantaviruses and elicits a high-titer neutralizing antibody response in Rhesus monkeys J Virol 2001, 75:8469-77 115092 11507192 10.1128/ JVI.75.18.8469-8477.2001
24. Kruger DH Ulrich R Lundkvist AA Hantavirus infections and their prevention Microbes Infect 2001, 3:1129-44 10.1016/S1286-4579(01)01474-5 11709294
25. Asada H Tamura M Kondo K Dohi Y Yamanishi K Cell-mediated immunity to virus causing hemorrhagic fever with renal syndrome: Generation of cytotoxic T lymphocytes J Gen Virol 1988, 69:2179-88 10.1099/ 0022-1317-69-9-2179 3137309
26. Lee KY Chun E Kim NY Seong BL Characterization of HLA-A2.1-restricted epitopes, conserved in both Hantaan and Sin Nombre viruses, in Hantaan virus-infected patients J Gen Virol 2002, 83:1131-6 11961268